Ledger.Open graph →
SEC Form D · Amendment · filed October 13, 2017

WELLESLEY PHARMACEUTICALS LLC

Offering
$5.8M
Sold
$3.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEWTOWN, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

David A. Dill · Newtown, PAExec · DirectorOmer A. Karahan · Newtown, PADirectorJoel M. Steinberg · NEW YORK, NYDirectorPeter Knell · Pasadena, CAExec · DirectorChristopher A. Lineberry · Bolton, MADirectorCandan A. Karabagli · Newtown, PADirectorGene W. Carlisle · Memphis, TNExec · DirectorThomas C. Schievelbein · NEW YORK, NYDirectorChristopher A. Lineberry · Bolton, MADirectorCandan A. Karabagli · Newtown, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗